BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1036 related articles for article (PubMed ID: 21357252)

  • 1. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
    Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
    Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
    Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
    Jiang TT; Luo XP; Sun JM; Gao J
    World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
    Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis].
    Streitparth F; Santosa F; Milz J; Gebauer B; Teichgräber U; Hamm B; Hidajat N
    Rofo; 2008 Oct; 180(10):899-905. PubMed ID: 19238640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
    Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis.
    Bauer J; Johnson S; Durham J; Ludkowski M; Trotter J; Bak T; Wachs M
    Liver Transpl; 2006 Oct; 12(10):1544-51. PubMed ID: 17004250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.
    Wang L; He F; Yue Z; Zhao H; Fan Z; Zhao M; Qiu B; Yao J; Lin Q; Dong X; Liu F
    Sci Rep; 2017 Sep; 7(1):10868. PubMed ID: 28883536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L
    Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
    Lakhoo J; Gaba RC
    Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
    Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z; Zhao H; Wang X; Zhang H; Jiang M; Tsauo J; Luo X; Yang L; Li X
    Abdom Imaging; 2015 Aug; 40(6):1813-20. PubMed ID: 25504374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.